We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Cyprotex | LSE:CRX | London | Ordinary Share | GB00BP25RZ14 | ORD £0.01 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 160.50 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
31/3/2019 03:50 | POST REMOVED | buywell2 | |
20/3/2019 00:06 | POST REMOVED | buywell2 | |
03/7/2017 07:40 | LiDCO had a good lift on friday , has any ex CRX holder joined the party ? I have been doing some more digging , and like what I am finding out check out todays LID post by buywell | buywell3 | |
23/6/2017 08:21 | It was a long and bumpy ride but CRX got there in the end I have to say trying to find a small cap company in the Pharma Biotech sector that is making profits, has no debt and has cash to aid a sales push is next to impossible, especially at a decent entry point. I don't like to follow herds, where valuations have become stretched. However Husbod , since you stayed the course here this post is for you, and I still don't like resource stocks I might add. This new product LiDCOunity v2 seems to have the potential to gain a decent market share in the USA. Edwards is the local USA based market leader , and has been for years now But clinical evidence has put Lidco ahead of that product and two other competitors That evidence was a few years ago on an older Lidco model (still being sold), but this new model with the same algorithm (IP protected) at its core , but with many new enhanced features could now prove pivotal in gaining increased USA sales together with the much increased number of USA sales staff. Over the next 3 years I expect Lidco to accelerate its USA presence with more USA selected states being targeted for sales by the addition of more sales staff. Plus ROW sales to continue to increase particularly in Asia. Lidco has a major market share within the UK NHS in its area of expertise with around 55%, this new product should help it maintain that lead. However it is in the USA where the company will make the most money now as the new CEO has identified and built his well thought out sales strategy upon. This guy Sassone , is an experienced sales specialist, he is what the company lacked ; now that there is no debt and over £4M cash to allow a long needed and targeted sales drive , primarily into the USA and secondarily into the ROW , turnover and bigger profits should in my opinion follow. The strategy report which starts on page 5 in the link below is one of the most concise and well detailed reports I have ever read in a small cap company , The recent change of chart shape over the last year supports my view, the market likes what it is seeing and hearing from Sassone. He has been incentivised via share options on a sliding scale re increased share price which includes him benefiting if Lidco should be bought out at a higher price within the sliding scale band.see page 19 I think Edwards will buy Lidco within 3 years. | buywell3 | |
12/1/2017 21:09 | Mine showed up this last Monday approx. | p1nkfish | |
11/1/2017 11:42 | Should chase up your broker had mine in December. | mathematic | |
11/1/2017 11:33 | Still waiting for money from my loan notes | lancasterbomber | |
02/1/2017 21:04 | No money yet in my account for CLNS. | p1nkfish | |
30/12/2016 11:37 | Yes, I have. No information on the calculation, but the money was credited to my Hargreaves Lansdown account,appears to be 1.60 for the shares already converted, + interest pro rata converted to new shares and 1.60 for those. | mathematic | |
30/12/2016 09:32 | Anyone got the money for their loan notes yet? | lancasterbomber | |
22/12/2016 16:28 | Money in from the shares but not the loan notes yet. | mrphil | |
19/12/2016 09:51 | Greetings buywell - I look forward to your observations. Payment day will be a day of mixed emotions. | husbod | |
18/12/2016 22:15 | when the money is paid I will say something | buywell3 | |
14/12/2016 12:20 | I'm gutted this company has been sold. I liked what it was trying to achieve and it's a shame we shareholders will no longer benefit from the growth of the business. Salty | saltaire111 | |
14/12/2016 11:47 | Thanks Husbod, in addition should receive the 5% pro rata i.e. about a quarter of the annual payment, to cover Sept-Dec of this year. | mathematic | |
14/12/2016 11:26 | Only all the details about the Scheme and boredom overcame me fairly soon into reading it. Take a look at Mr Phil's earlier post re the calculations and I would have thought that payment will be made either tomorrow when the shares are cancelled or very soon after. There is a further RNS due out today according to the RNS already issued and that might contain more details. | husbod | |
14/12/2016 11:02 | Has anyone received any communication from the company, or it's brokers, about the convertible loan stock? | mathematic | |
13/12/2016 10:11 | Scheme Court hearing today, suspension of shares tomorrow and cancellation of shares on Thursday if everything goes to plan. So our lovely little UK company will cease to exist in less than 72 hours. I thought buywell might pop back in with his final thoughts and maybe give us an idea on any other tiddlers in this sector that could prove to be the next CRX. Not sure when we receive our loot though - should it be in our accounts on Thursday I wonder? | husbod | |
12/12/2016 10:24 | saltaire - see RNS of 1/12 | husbod | |
07/12/2016 20:11 | Thanks MrPhil. That's better than I thought as I was wondering if they would simply return the original capital plus the increase already credited. Presumably the income tax deduction will apply to the additional notes issued in lieu of interest with the uplift in the original take up being taxable as capital gain. | husbod | |
06/12/2016 21:20 | Does anyone know the completion date? Salty | saltaire111 | |
06/12/2016 16:05 | What about where the original loan amount was say £1000, which by this method would give 1,666 Shares however because of interest paid over previous years the holder now owns 1,666 + plus the number added as a result of interest | lancasterbomber | |
06/12/2016 11:07 | Hi Husbod, excerpt from the letter. Example of how the Loan Note Proposal will work If a loan note holder holds £10,000 of Loan Notes (including PIK Notes) he will be assumed to have received the following number of Shares:- 10,000 / 0.6 = 16,666 and two-thirds Shares The amount paid on redemption of the Loan Notes will be 160 pence multiplied by 16,666 and two-thirds, i.e. £26,666.67. This amount will be paid subject to relevant deductions for income tax. | mrphil |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions